Medicine needs to embrace open source

Here’s what I do know: Open source and data produces better results than proprietary methods. Open Source Pharma, an organization devoted to building on existing initiatives to develop an alternative, comprehensive, open-source pharmaceutical system, is leading the way. While it’s tempting to villainize Pfizer, which announced in 2018 it was ending all its efforts to develop new Alzheimer’s drugs because they weren’t “promising” [read profitable] enough, it is just taking advantage of a broken patent system that rewards broken, proprietary intellectual property (IP) methods.

Source: www.zdnet.com